Gal-3 is a recognised ligand of the lymphocyte activation gene-3 (LAG-3), an immune checkpoint receptor expressed on the surface of effector T cells and regulatory T cells, and associated with worse prognosis in several cancers (13). Here, LGALS3 is linked to cancer.